Role of Cancer-associated Fibroblast, MDSCs and Immune Cell Interplays in the Resistance of Non-small Cell Lung Cancer to Anti-PD1/PD-L1 Therapies

Clinical trial NCT06024538 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06024538
Sponsor: University Hospital, Bordeaux
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Lung Neoplasm Cancer Associated Fibroblast Myeloid-Derived Suppressive Cells Immunosuppression

Start date: 2025-12-01
Primary completion: 2026-12-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.